What happened, and who moved.
Kilroy Realty's Oyster Point development in Southern California has achieved 50% lease occupancy in its second phase amid softer demand for life sciences space.
A pharmaceutical company has leased 40,000 square feet at One Lincoln in downtown Boston, relocating its headquarters from suburban locations.
BOSTON — Ratio Therapeutics has signed a 17,000-square-foot office lease expansion in Boston’s Seaport District. The developer of radiopharmaceuticals for cancer patients will remain at the Innovation & Design Building, a 1.4 million-square-foot mixed-use property that was originally constructed in 1918 as a…
Alexandria Real Estate Equities captured twice its market share of San Francisco Bay Area leasing in the second quarter, its strongest regional showing, as advanced technology users supplied nearly 30 percent of companywide volume and the REIT closed a $163 million Palo Alto sale to a residential developer. The…
A biotechnology firm is relocating its lab space from West Harlem to Midtown South. Volastra Therapeutics signed an 18,120-square-foot lease in the Alexandria Center for Life Science at 430 East 29th Street, owned by Alexandria Real Estate Equities, according to CBRE. Volastra is subleasing space on the 11th floor…
The real estate investment trust said active tenant demand in San Francisco has topped 10 million square feet for the first time since 2019, with the recovery broadening from the city's core into SoMa, the Peninsula and its South San Francisco life science campus. The post Kilroy Says San Francisco Demand Tops 10MM…
The second phase of Kilroy Realty's sprawling Oyster Point life sciences campus in South San Francisco is climbing uphill in a bid to fill space as the lab leasing market languishes. Although the first phase of the 865K SF campus is 100% leased, the...
AdvanCell has signed a full-building lease at an innovation park facility in Andover, representing a major occupier commitment to the property.
A 70,000 sq ft life sciences property (Kova KX) has been pre-let to LifeArc in a major UK letting transaction.
DivcoWest said Monday that Collegium Pharmaceutical has signed a headquarters lease for 40,288 square feet on floors 11 and 12 at One Lincoln in Boston’s Financial District, relocating from suburban Stoughton, MA. Slated for the first quarter of 2027, Collegium’s arrival adds a life science presence to a tenant…
Roche is decommissioning the specialized clinical testing laboratory it inherited from its 2015 Ariosa Diagnostics acquisition and moving all 45 employees roughly nine miles north to a purpose-built 11,300-square-foot lab on its Santa Clara campus, a consolidation triggered by a lease expiration and executed…
Upside Foods, the cultivated meat company that raised more than $600 million at a billion-dollar valuation and then cut staff three times in 13 months, has leased 18,505 square feet at 6101 Christie Avenue in Emeryville, a lease that appeared on the Bay Area’s life sciences roster in the same quarter that a nearby…
Natera, the multibillion-dollar genetic testing company that moved its headquarters to Austin but kept its scientific core on the Peninsula, has leased 19,652 square feet at 2 Tower Place in South San Francisco, a Ventas-owned tower where the commitment lands as the company’s existing South San Francisco lease…
Clinical-stage breast cancer company Olema Oncology has committed to 38,176 square feet at Kilroy Realty’s 365 Oyster Point Boulevard under a seven-year lease, relocating its headquarters out of San Francisco and pushing the building to roughly 60 percent leased months before the pivotal readout that will determine…